Genentech Asks For Sanctions In Kadcyla Patent Suit
Genentech Inc. asked a California federal judge Tuesday to throw out a patent lawsuit targeting its breast cancer treatment drug Kadcyla and sanction the Atlanta research company that filed the case,...To view the full article, register now.
Already a subscriber? Click here to view full article